The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): test development and

A M Glanzman1, E Mazzone, M Main

  • 1Department of Physical Therapy, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. glanzmana@email.chop.edu

Insights

The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) reliably measures motor skills in infants with spinal muscular atrophy type I (SMA-I). This new tool is crucial for clinical trials evaluating SMA-I treatments.

Area of Science:

  • Pediatric Neurology
  • Neuromuscular Disorders
  • Clinical Outcome Measures

Background:

  • Spinal muscular atrophy type I (SMA-I) severely limits infant motor skills.
  • Quantifying motor abilities in SMA-I is challenging, lacking validated clinical trial outcome measures.
  • Existing assessments do not adequately capture the specific motor deficits in SMA-I.

Purpose of the Study:

  • To develop and validate a reliable motor function assessment for infants with SMA-I.
  • To introduce the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND) as a clinical outcome measure.
  • To establish the psychometric properties of the CHOP INTEND for use in research and clinical settings.

Main Methods:

  • The CHOP INTEND was developed using data from 26 infants with SMA-I, incorporating items from existing tests and expert evaluation.
  • Item selection for the CHOP INTEND was guided by statistical analysis (mean, standard deviation, frequency distribution, Chronbach's alpha).
  • Reliability was assessed through intra-rater (test-retest) and inter-rater (video analysis) analyses in infants with and without neuromuscular disease.

Main Results:

  • The CHOP INTEND demonstrated high intra-rater reliability (ICC=0.96) and inter-rater reliability (ICC=0.98 and 0.93).
  • Expert panel input supported the face validity of the CHOP INTEND.
  • The test effectively evaluates motor skills in infants with SMA-I and other infantile neuromuscular disorders.

Conclusions:

  • The CHOP INTEND is a reliable and valid measure for assessing motor function in infants with SMA-I.
  • This tool addresses the critical need for a validated outcome measure in SMA-I clinical trials.
  • Further validation studies are recommended to expand the utility of the CHOP INTEND.

Related Concept Videos